Home About us Reports Charts News Custom Company Scan  
Report Charts News
Title Content
Life Sciences
  Metals & Minerals
Public Sector
  Finance Service
  Real Estate
Technology And Media

Tel: 0086-10-82600828
Fax: 0086-10-82601570

 Beijing SL Pharmaceutical invested PnuVax and entered into high-end vaccine market
CreateTime:2011-09-08     Source:ResearchInChina Editor:hangmei
Text Size:       
Beijing SL Pharmaceutical announced on 13th Aug, that it will invest RMB130 million to set up joint-venture PnuVax SL with Canadian company PnuVax Incorporated. SL Pharmaceutical and PnuVax will ho...
Forget password? get password
Welcome to our website.
This service is open to member only.

Contact our customer service team
Tel: 86-10-82600828, 82601561
Email: report@researchinchina.com

Related Reports
China Animal Vaccine Industry Report, 2019-2025
China Blood Product Industry Report, 2020-2026
China Vacuum Blood Collection Device Industry Report, 2019-2025
China Human Vaccine Industry Report, 2019-2025
China Independent Clinical Laboratory Industry Report, 2019-2025
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1